Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Treatment
7 results:

  • 1. Outcomes Following treatment with FOLFOX for Patients with Resectable or Potentially Resectable Metastatic colorectal cancer: A Population-based Cohort Study.
    Habbous S; Tai X; Gill T; Arias J; Beca J; Raphael MJ; Kennedy E; Biagi JJ; Chan KKW
    Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):188-198. PubMed ID: 36610878
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
    Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
    Medicine (Baltimore); 2019 Aug; 98(33):e16771. PubMed ID: 31415377
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CT-based Radiomics Signature to Discriminate High-grade From Low-grade colorectal Adenocarcinoma.
    Huang X; Cheng Z; Huang Y; Liang C; He L; Ma Z; Chen X; Wu X; Li Y; Liang C; Liu Z
    Acad Radiol; 2018 Oct; 25(10):1285-1297. PubMed ID: 29503175
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [wt1 Class I Peptide/wt1 Class II Peptide Pulsed Dendritic Cell Therapy Efficacy in 60 Patients with a Wide Range of Advanced cancers].
    Kato Y
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1252-1255. PubMed ID: 27760951
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Efficacy of wt1 peptide-/MUC-1 peptide-pulsed dendritic cell therapy in 313 patients with a wide range of cancers].
    Kato Y
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1280-2. PubMed ID: 25335717
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Report of the National Oncology Research and Developement Consortium, 2003].
    Tímár J
    Magy Onkol; 2004; 48(1):75-9. PubMed ID: 15105900
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.